T.J. OSHIE OF THE WASHINGTON CAPITALS HOSTS BROOMBALL FUNDRAISER TO BENEFIT THE ALZHEIMER’S DRUG DISCOVERY FOUNDATION
|
|
|
T.J. Oshie, in partnership with WARROAD, the Super Service Challenge, and NT Concepts, hosted a broomball tournament on Wednesday, February 5th at MedStar Capitals Iceplex, which raised over $40,000 for the Alzheimer’s Drug Discovery Foundation (ADDF). Oshie became involved with the ADDF as a result of his father’s struggle with Alzheimer’s disease, and was honored last year at the ADDF Great Ladies Luncheon in Washington, D.C. Read more.
|
|
Grants Announcements
The Alzheimer’s Drug Discovery Foundation announced ten new investments, totaling $13.25 million, to help advance research programs focused on novel therapeutic targets and innovative avenues for the treatment and prevention of Alzheimer’s disease and related dementias. Read more.
|
|
ADDF Statement on DIAN-TU Trials
In response to the recently released results of the Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), Dr. Howard Fillit expressed his disappointment that patients in the study did not see a benefit and reiterated the ADDF’s support for a broader approach that moves past targeting beta-amyloid. Read more.
|
|
Remembering Bruce McEwen
Over this past month, we remembered the legacy of Dr. Bruce S. McEwen, a neuroscience pioneer and longtime member of the ADDF’s Board of Governors. Learn more about Dr. McEwen’s extraordinary life and scientific accomplishments.
|
|
Cognitive Vitality Reports
The Alzheimer’s Drug Discovery Foundation recently launched Cognitive Vitality Reports, a new resource on CognitiveVitality.org that currently contains over 200 reports for researchers and clinicians interested in the development of drugs for Alzheimer’s and related dementias.
|
|
| |
| 3rd Annual Hope on the Horizon Palm Beach Luncheon |
| This event will honor Judy Glickman Lauder and will feature an intimate conversation about the most promising novel Alzheimer’s drugs with Howard Fillit, MD, and Ronald Crystal, MD, Chairman of Genetic Medicine, Weill Cornell Medical College. The event is currently sold out. Learn more.
|
|
| 2020 Aging in America Conference |
| Our ADDF neuroscientists will be hosting a booth on Cognitive Vitality at the conference, which this year will focus on issues impacting our increasingly diverse and multicultural older adult population. Learn more. |
|
| |
| 3rd Annual Memories Matter |
| This event is at Pier 60 in New York City and will feature cocktails and dinner, an informative program, a silent auction, and special guests, with all proceeds supporting the ADDF. Purchase tickets. |
|
| |
| 14th Annual Drug Discovery for Neurodegeneration Workshop |
| Our annual workshop serves as an introduction to all aspects of drug discovery for neurodegenerative diseases, providing opportunities for participants to gain a valuable understanding of the drug discovery pipeline, from target identification to clinical trials. Register here. |
|
|
ADDF IN THE NEWS
- T.J. Oshie’s broomball fundraiser to benefit the ADDF was picked up by news outlets such as Fox 5 WTTG and ABC 7 WJLA, as well as being mentioned in prominent social media accounts, including a retweet from the Washington Capitals.
- Dr. Howard Fillit accepted an honorary degree from the University of Exeter in December. In his speech, he said, “Today the ADDF is closer than ever to finding effective treatments for this disease and I have had the privilege of being part of that worldwide effort.” Watch the full speech here.
- The ADDF’s partnership with Janssen Pharmaceutical Companies was highlighted in an article by Johnson & Johnson about the fight against Alzheimer’s disease. Read here.
- Dr. Howard Fillit was quoted in an article from Medscape about the recently released results of the DIAN-TU trials. Read here.
|
|
|
|
|
|
